Conexeu Sciences Shares Rise on Advancement of Tissue Restoration Platform
Dow Jones
Oct 07
Shares of Conexeu Sciences rose after the medical device and regenerative medicine company reported progress for its CXU tissue restoration platform.
The stock was up 11% to $3.45 in Tuesday afternoon trading. Shares have traded in range of $3.05 to $18.79 since their debut on Nasdaq via a direct listing.
The company said it has advanced manufacturing scale-up, regulatory testing and preclinical work supporting a planned 510(k) submission to the Food and Drug Administration in the first quarter of 2027.
Multiple scaled-up batches of CXU material met company specifications for key material characteristics and product performance measures, the company said.
CXU is a collagen-based extracellular matrix platform.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.